Pharsight

PROQR THERAPEUTICS II BV PATENTS FACING OPPOSITIONS

Top patents of PROQR THERAPEUTICS II BV facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3507366B1 07 Oct, 2020 Chemically Modified Single-Stranded Rna-Editing Oligonucleotides Aug, 2037 1